Xie Lin, Wang Qun, Lu Hengcheng, Kuang Maobin, He Shiming, Xie Guobo, Sheng Guotai, Zhang Shuhua, Wang Wei, Zou Yang
Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Front Endocrinol (Lausanne). 2024 Dec 23;15:1444663. doi: 10.3389/fendo.2024.1444663. eCollection 2024.
The deterioration of acute decompensated heart failure (ADHF) is associated with abnormal activation of inflammatory pathways. This study aims to evaluate the impact and predictive value of a novel inflammatory marker, the systemic inflammation response index (SIRI), on short-term adverse outcomes in ADHF patients.
This retrospective cohort study included 1,448 ADHF patients from Jiangxi Provincial People's Hospital between 2019-2022. SIRI was calculated using the formula: (neutrophil count × monocyte count)/lymphocyte count. In the correlation analysis, the study outcome was the 30-day mortality in patients with ADHF. Cox regression analysis and receiver operating characteristic curves were employed to investigate the risk assessment and predictive value of the SIRI for 30-day mortality in ADHF patients. Finally, we also exploratively assessed the mediation effect of nutritional factors (albumin: Alb, total cholesterol: TC, and lymphocyte count) on the association between SIRI and 30-day mortality in ADHF patients.
During the 30-day follow-up, 53 deaths were recorded. Mortality rates across SIRI tertiles were 0.62%, 2.07%, and 8.28%, respectively. There was a significant linear positive correlation between SIRI and 30-day mortality in ADHF patients (HR: 1.21; for non-linearity = 0.113). Additionally, compared to ADHF patients with low SIRI, those with high SIRI had a 685% increased risk of 30-day mortality (HR: 7.85). Furthermore, receiver operating characteristic curve analysis demonstrated that SIRI significantly improved the predictive value for 30-day mortality in ADHF patients compared to neutrophil count, monocyte count, and lymphocyte count alone (AUC: neutrophil count 0.7633, monocyte count 0.6835, lymphocyte count 0.7356, SIRI 0.8237; all DeLong <0.05). Mediation analyses indicated that, except for lymphocyte count, both Alb and TC had significant indirect effects on the SIRI-related 30-day mortality in ADHF patients; Specifically, Alb accounted for approximately 24.46% of the mediation effect, while TC accounted for approximately 13.35%.
This cohort study based on a Southern Chinese population demonstrates a significant linear positive correlation between SIRI and 30-day mortality in ADHF patients, highlighting its substantial predictive value. Incorporating SIRI into the monitoring regimen of ADHF patients may be crucial for preventing further disease progression.
急性失代偿性心力衰竭(ADHF)的恶化与炎症途径的异常激活有关。本研究旨在评估一种新型炎症标志物——全身炎症反应指数(SIRI)对ADHF患者短期不良结局的影响及预测价值。
这项回顾性队列研究纳入了2019年至2022年期间来自江西省人民医院的1448例ADHF患者。SIRI采用公式计算:(中性粒细胞计数×单核细胞计数)/淋巴细胞计数。在相关性分析中,研究结局为ADHF患者的30天死亡率。采用Cox回归分析和受试者工作特征曲线来研究SIRI对ADHF患者30天死亡率的风险评估和预测价值。最后,我们还探索性评估了营养因素(白蛋白:Alb、总胆固醇:TC和淋巴细胞计数)对ADHF患者中SIRI与30天死亡率之间关联的中介作用。
在30天的随访期间,记录到53例死亡。SIRI三分位数组的死亡率分别为0.62%、2.07%和8.28%。ADHF患者的SIRI与30天死亡率之间存在显著的线性正相关(HR:1.21;非线性检验P = 0.113)。此外,与SIRI低的ADHF患者相比,SIRI高的患者30天死亡率风险增加685%(HR:7.85)。此外,受试者工作特征曲线分析表明,与单独的中性粒细胞计数、单核细胞计数和淋巴细胞计数相比,SIRI显著提高了对ADHF患者30天死亡率的预测价值(AUC:中性粒细胞计数0.7633,单核细胞计数0.6835,淋巴细胞计数0.7356,SIRI 0.8237;所有DeLong检验P<0.05)。中介分析表明,除淋巴细胞计数外,Alb和TC对ADHF患者中与SIRI相关的30天死亡率均有显著的间接影响;具体而言,Alb约占中介作用的24.46%,而TC约占13.35%。
这项基于中国南方人群的队列研究表明,ADHF患者的SIRI与30天死亡率之间存在显著的线性正相关,突出了其重要的预测价值。将SIRI纳入ADHF患者的监测方案可能对预防疾病进一步进展至关重要。